Zoetis Inc. $ZTS Shares Acquired by Chicago Partners Investment Group LLC

Key Points

• Chicago Partners Investment Group LLC increased its holdings in Zoetis Inc. by 67% during the second quarter, now owning 4,886 shares valued at approximately $750,000.
• Several analysts have adjusted their price targets for Zoetis, with Leerink Partners lowering theirs from $180 to $155, while Piper Sandler raised it to $215.
• Zoetis recently reported earnings of $1.76 per share for the latest quarter, surpassing estimates, and announced a quarterly dividend of $0.50 per share.

Chicago Partners Investment Group LLC lifted its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 67.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,886 shares of the company's stock after buying an additional 1,961 shares during the quarter. Chicago Partners Investment Group LLC's holdings in Zoetis were worth $750,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ZTS. Lindbrook Capital LLC grew its stake in shares of Zoetis by 1.8% during the 1st quarter. Lindbrook Capital LLC now owns 3,715 shares of the company's stock worth $612,000 after purchasing an additional 65 shares during the period. Scott & Selber Inc. raised its holdings in Zoetis by 0.6% during the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company's stock worth $1,817,000 after purchasing an additional 67 shares during the last quarter. Secure Asset Management LLC raised its holdings in Zoetis by 2.9% during the second quarter. Secure Asset Management LLC now owns 2,448 shares of the company's stock worth $382,000 after purchasing an additional 68 shares during the last quarter. Quotient Wealth Partners LLC boosted its position in Zoetis by 2.3% during the first quarter. Quotient Wealth Partners LLC now owns 3,167 shares of the company's stock worth $521,000 after purchasing an additional 72 shares in the last quarter. Finally, Menard Financial Group LLC grew its holdings in Zoetis by 3.8% in the first quarter. Menard Financial Group LLC now owns 2,032 shares of the company's stock valued at $305,000 after purchasing an additional 75 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on ZTS. Leerink Partners lowered shares of Zoetis from an "outperform" rating to a "market perform" rating and decreased their price objective for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. UBS Group cut their target price on shares of Zoetis from $165.00 to $158.00 and set a "neutral" rating for the company in a research report on Monday. Piper Sandler increased their price target on shares of Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a research report on Monday, August 11th. Weiss Ratings reissued a "hold (c-)" rating on shares of Zoetis in a research note on Wednesday, October 8th. Finally, Argus reaffirmed a "buy" rating and issued a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Zoetis has a consensus rating of "Hold" and a consensus price target of $195.00.

Zoetis Trading Up 0.7%

Shares of Zoetis stock opened at $146.13 on Wednesday. Zoetis Inc. has a fifty-two week low of $139.34 and a fifty-two week high of $189.98. The firm has a market cap of $64.76 billion, a PE ratio of 25.15, a P/E/G ratio of 2.33 and a beta of 0.90. The business's fifty day moving average is $148.58 and its two-hundred day moving average is $153.55. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the company posted $1.56 EPS. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis's dividend payout ratio is currently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.